Topic Hub
11 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 11 of 11 clinical reviews.
Secondary hypogonadism frequently co-occurs with depression, anxiety, and cognitive decline. Learn how hypothalamic-pituitary dysfunction links low testosterone to mental health conditions, and what evidence-based treatments can help.
Read clinical reviewA step-by-step diagnostic algorithm for secondary hypogonadism, covering morning testosterone testing, LH/FSH interpretation, pituitary imaging, and when to refer, grounded in Endocrine Society and AUA guidelines.
Read clinical reviewA side-by-side comparison of major society guidelines for diagnosing and treating secondary hypogonadism, including diagnostic thresholds, treatment algorithms, and fertility-preserving options.
Read clinical reviewHow secondary hypogonadism presents and is managed in obesity, type 2 diabetes, opioid use, HIV, CKD, and other special populations. Evidence-based guidance from the Endocrine Society, ADA, and AACE.
Read clinical reviewEvidence-based monitoring schedule for secondary hypogonadism, including lab timing, hormone targets, and follow-up intervals from the Endocrine Society, AUA, and AACE guidelines.
Read clinical reviewEvidence-based treatment algorithm for secondary hypogonadism, organized by line of therapy. Covers lifestyle modification, clomiphene, enclomiphene, hCG, and testosterone replacement with guideline citations from the Endocrine Society, AUA, and AACE.
Read clinical reviewA guide for caregivers and family members supporting someone with secondary hypogonadism, covering diagnosis, treatment options, emotional support strategies, and clinical resources.
Read clinical reviewA physician-reviewed guide to secondary hypogonadism comorbidities, including type 2 diabetes, obesity, sleep apnea, hyperprolactinemia, and opioid use, with diagnostic criteria, treatment options, and Endocrine Society guideline references.
Read clinical reviewA clinical review of the latest trials, investigational therapies, and guideline updates reshaping how secondary hypogonadism is diagnosed and treated, including oral enclomiphene, kisspeptin agonists, and selective androgen receptor modulators.
Read clinical reviewHow inherited gene variants and familial patterns contribute to secondary hypogonadism, what genetic tests are available, and when clinicians should suspect a hereditary cause.
Read clinical reviewEvidence-based nutrition and lifestyle strategies for secondary hypogonadism, including weight loss targets, micronutrient optimization, sleep protocols, and exercise programming to restore hypothalamic-pituitary-gonadal axis function.
Read clinical review